Emerging Infectious Diseases (Feb 2007)

Campylobacter Antimicrobial Drug Resistance among Humans, Broiler Chickens, and Pigs, France

  • Anne Gallay,
  • Valérie Prouzet-Mauléon,
  • Isabelle Kempf,
  • Philippe Lehours,
  • Leila Labadi,
  • Christine Camou,
  • Martine Denis,
  • Henriette de Valk,
  • Jean-Claude Desenclos,
  • Francis Mégraud

DOI
https://doi.org/10.3201/eid1302.060587
Journal volume & issue
Vol. 13, no. 2
pp. 259 – 259

Abstract

Read online

We describe isolates from human Campylobacter infection in the French population and the isolates' antimicrobial drug resistance patterns since 1986 and compare the trends with those of isolates from broiler chickens and pigs from 1999 to 2004. Among 5,685 human Campylobacter isolates, 76.2% were C. jejuni, 17.2% C. coli, and 5.0% C. fetus. Resistance to nalidixic acid increased from 8.2% in 1990 to 26.3% in 2004 (p<10-3), and resistance to ampicillin was high over time. Nalidixic acid resistance was greater for C. coli (21.3%) than for C. jejuni (14.9%, p<10-3). C. jejuni resistance to ciprofloxacin in broilers decreased from 31.7% in 2002 to 9.0% in 2004 (p = 0.02). The patterns of resistance to quinolones and fluoroquinolones were similar between 1999 and 2004 in human and broiler isolates for C. jejuni. These results suggest a potential benefit of a regulation policy limiting use of antimicrobial drugs in food animals.

Keywords